SCHEMBL1503464

SCHEMBL1503464

C[CH]c1c(C)c(C)c(C)c(C)c1C

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13138700 0.69 L3MBTL1 (0.35) L3MBTL1
SCHEMBL13138698 0.69 L3MBTL1 (0.35) L3MBTL1
SCHEMBL14993107 0.69 L3MBTL1 (0.35) L3MBTL1
SCHEMBL5248091 0.69 CYP1A2 (0.36) L3MBTL1
SCHEMBL1610774 0.68 ALDH1A1 (0.31)
SCHEMBL10465875 0.65
Hexamethylbenzene SCHEMBL114857 0.65 RXFP1 (0.33)
SCHEMBL18354289 0.64 L3MBTL1 (0.36) L3MBTL1
SCHEMBL81003 0.64 L3MBTL1 (0.36) L3MBTL1
SCHEMBL599509 0.64 L3MBTL1 (0.36) L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007135417-A1 BENZOTRIAZEPINONE DERIVATIVES JAMES BLACK FOUNDATION (GB) 2007-11-29 WO claimed
WO-2007135350-A1 BENZOTRIAZEPINONE DERIVATIVES JAMES BLACK FOUNDATION (GB) 2007-11-29 WO claimed
WO-2006129120-A9 BENZOTRIAZEPINONE DERIVATIVES JAMES BLACK FOUNDATION (GB) 2007-03-22 WO claimed
WO-2006129120-A2 BENZOTRIAZEPINONE DERIVATIVES JAMES BLACK FOUNDATION (GB) 2006-12-07 WO claimed
US-6451937-B1 BY THERMALLY REACTING A FUNCTIONALIZING REAGENT AND THE HYDROCARBON IN THE PRESENCE OF A TRANSITION METAL COORDINATION CATALYST SHELL OIL COMPANY 2002-09-17 US claimed
US-20010039349-A1 Selective, Catalytic, thermal functionalization of secondary or aromatic C-H cyclic hydrocarbon bonds SHELL OIL COMPANY 2001-11-08 US claimed
US-4159943-A Froth flotation of ores using hydrocarbyl bicarbonates PETROVICH VOJISLAV 1979-07-03 US claimed
US-11931415-B2 Ophthalmic compositions THE UNIVERSITY OF LIVERPOOL (GB) 2024-03-19 US disclosed
CN-110632207-B Method for identifying mold based on volatile gas components and evolution trend thereof 南京财经大学 2022-04-29 CN disclosed
EP-3496760-B1 OPHTHALMIC COMPOSITIONS UNIV LIVERPOOL (GB) 2022-02-09 EP disclosed
US-20210220335-A1 NITROIMIDAZOLE FORMULATIONS IRP Health Pty Ltd (AU) 2021-07-22 US disclosed
EP-3810137-A1 NITROIMIDAZOLE FORMULATIONS IRP Health Pty Ltd (AU) 2021-04-28 EP disclosed
WO-2021072473-A1 ANTIMICROBIALS AS FEED PRESERVATIVES IRP Health Pty Ltd (AU) 2021-04-22 WO disclosed
WO-2007068890-A1 ANTIMICROBIAL POLYURETHANE FOAMS ETHICON, INC. (US) 2007-06-21 WO disclosed
WO-2006129120-A9 BENZOTRIAZEPINONE DERIVATIVES JAMES BLACK FOUNDATION (GB) 2007-03-22 WO disclosed
WO-2006129120-A2 BENZOTRIAZEPINONE DERIVATIVES JAMES BLACK FOUNDATION (GB) 2006-12-07 WO disclosed
EP-1259517-B1 SELECTIVE, CATALYTIC, AND THERMALLY INDUCED FUNCTIONALIZATION OF PRIMARY C-H BONDS IN HYDROCARBONS SHELL INT RESEARCH (NL) 2003-09-17 EP disclosed
EP-1259517-A1 SELECTIVE, CATALYTIC, AND THERMALLY INDUCED FUNCTIONALIZATION OF PRIMARY C-H BONDS IN HYDROCARBONS SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 2002-11-27 EP disclosed
WO-2001064689-A1 SELECTIVE, CATALYTIC, AND THERMALLY INDUCED FUNCTIONALIZATION OF PRIMARY C-H BONDS IN HYDROCARBONS SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2001-09-07 WO disclosed
US-4159943-A Froth flotation of ores using hydrocarbyl bicarbonates PETROVICH VOJISLAV 1979-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210220335-A1 NITROIMIDAZOLE FORMULATIONS PHB1, COX5B, CYP3A5 L3MBTL1 1046/4885
US-11931415-B2 Ophthalmic compositions CRYAB, CRYAA, PDE6D L3MBTL1 4679/4885
US-20010039349-A1 Selective, Catalytic, thermal functionalization of secondary or aromatic C-H cyclic hydrocarbon bonds AHR, PAH, HRH3 L3MBTL1 3731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.